Monday, June 20, 2016

BRIEF-Adaptimmune Therapeutics receives positive opinion

* Adaptimmune receives positive opinion for orphan drug

designation in the European Union for spear t-cell therapy

targeting NY-ESO for treatment of soft tissue sarcoma

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)